Supplier: Propranolol hydrochloride(cas no.: 318-98-9), furosemide (cas no.: 54-31-9), telmisartan(cas no.: 144701-48-4), clotrimazole(cas no.: 23593-75-1), folic acid £¨cas no.: 59-30-3£©, lithium carbonate£¨ cas no.554-13-2£©, and intermediates:, 2-n-propyl-4-methyl-6-(1-methyl benzimidazole-2-yl)-1h-benzimidazole(cas no.:152628-02-9, intermediates of telmisartan£©, methyl-4-methyl-biphenyl 2-carboxylate(casno.:114772-34-8), 2-n-propyl-4-methyl-6-carboxylate-1h-benzimidazole(cas no.:152628-03-0), methyl-4-(butyrylamino)-3-methyl-5-nitrobenzoate(cas no.:152628-01-8), o-chlorphenyl-diphenyl-chloromethane(cas no.: 42074-68-0 intermediates of clotrimazole), rosuvastatin intermediates zd-9(cas no.: 289042-10-0), 4-(acetyloxy)-2-(ethylthio)-6, 7-difluoro-3-quinolinecarboxylic acid, ethylester£¨cas no: 154330-68-4, intermediate of plulifloxacin pl-7£©, 6, 7-difluoro-1-methyl-4-oxo-1h, 4h-[1, 3]thiazeto[3, 2-a]quinoline-3-carboxylic acid, ethyleste